Cargando…
Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa
BACKGROUND: As stavudine remains an important and widely prescribed drug in resource-limited settings, the effect of a reduced dose of stavudine (from 40 mg to 30 mg) on outcomes of highly active antiretroviral therapy (HAART) remains an important public health question. METHODS: We analyzed prospec...
Autores principales: | Maskew, Mhairi, Westreich, Daniel, Fox, Matthew P, Maotoe, Thapelo, Sanne, Ian M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313885/ https://www.ncbi.nlm.nih.gov/pubmed/22410312 http://dx.doi.org/10.1186/1758-2652-15-13 |
Ejemplares similares
-
Toxicity Associated with Stavudine Dose Reduction from 40 to 30 mg in First-Line Antiretroviral Therapy
por: Pujades-Rodríguez, Mar, et al.
Publicado: (2011) -
A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects
por: Menezes, Colin N, et al.
Publicado: (2011) -
Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen
por: Takuva, Simbarashe, et al.
Publicado: (2013) -
Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011) -
Incidence of Pregnancy after Initiation of Antiretroviral Therapy in South Africa: A Retrospective Clinical Cohort Analysis
por: Westreich, Daniel, et al.
Publicado: (2012)